Revisions to 2025 Jobs Data Paint Weaker Labor Market Picture Indeed Hiring Lab Analysis Shows Sindhu Trade Links Shares Rise After Approving Acquisitions and Capital Increase Bond Bull Market May Pause but Far from Over Says Expert Adding Value Component to Growth ETF May Enhance MemoryChip Rally DIIs Increase Holdings in 10 LargeCap Stocks for Fourth Consecutive Quarter Grubhub Launches Gold Days Event with BOGO Deals at Jersey Mikes and Other Chains Throughout May CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment VIVS Q3 2025 Earnings EPS Beat Surprises Market Amid Challenging Environment GABC Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline KRNY Q1 2026 Earnings Slight EPS Miss Weighs on Shares After Mixed Quarter Pixelworks PXLW Q1 2026 Earnings Massive EPS Surprise Driven by Extraordinary Items STIM Q1 2026 Earnings EPS Beats Estimates as Cost Control Shines Revenue Unreported DTE Energy Debentures DTK Hold Steady Near Resistance as Yield Attracts Income Seekers OFS Capital Corporation 495 Notes due 2028 OFSSH Hold Steady at 239 as Market Awaits Direction American Superconductor AMSC Slips 256 as Shares Test Support Levels Amid Sector Rotation Morgan Stanley Emerging Markets Domestic Debt Fund EDD Rises 11 as Emerging Market Debt Shows Resilience Adobe Inc ADBE Holds Steady Near Resistance A Measured Advance Trump Signals No Rush on Iran Nuclear Deal Criticizes Opponents as Losers CAKE Q1 2026 Earnings EPS Beats Estimates Amid Steady Operations Ross Stores ROST Surges Over 8 Retail Resilience in Focus CDLX Q1 2026 Earnings NarrowerThanExpected Loss Signals Operating Discipline CAPL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies CVNA Q1 2026 Earnings EPS Beats Estimates as Earnings Surge Past Expectations Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances EDIT Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher UNB Q2 2025 Earnings Solid EPS Performance Amidst Quiet Quarter Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline